Author:
Setiawan Devin,Wiranto Yumiko,Girard Jeffrey M.,Watts Amber,Ashourvan Arian
Abstract
AbstractBackgroundTraditional clinical assessments often lack individualization, relying on standardized procedures that may not accommodate the diverse needs of patients, especially in early stages where personalized diagnosis could offer significant benefits. We aim to provide a machine-learning framework that addresses the individualized feature addition problem and enhances diagnostic accuracy for clinical assessments.MethodsIndividualized Clinical Assessment Recommendation System (iCARE) employs locally weighted logistic regression and Shapley Additive Explanations (SHAP) value analysis to tailor feature selection to individual patient characteristics. Evaluations were conducted on synthetic and real-world datasets, including early-stage diabetes risk prediction and heart failure clinical records from the UCI Machine Learning Repository. We compared the performance of iCARE with a Global approach using statistical analysis on accuracy and area under the ROC curve (AUC) to select the best additional features.FindingsThe iCARE framework enhances predictive accuracy and AUC metrics when additional features exhibit distinct predictive capabilities, as evidenced by synthetic datasets 1-3 and the early diabetes dataset. Specifically, in synthetic dataset 1, iCARE achieved an accuracy of 0·999 and an AUC of 1·000, outperforming the Global approach with an accuracy of 0·689 and an AUC of 0·639. In the early diabetes dataset, iCARE shows improvements of 1·5-3·5% in accuracy and AUC across different numbers of initial features. Conversely, in synthetic datasets 4-5 and the heart failure dataset, where features lack discernible predictive distinctions, iCARE shows no significant advantage over global approaches on accuracy and AUC metrics.InterpretationiCARE provides personalized feature recommendations that enhance diagnostic accuracy in scenarios where individualized approaches are critical, improving the precision and effectiveness of medical diagnoses.FundingThis work was supported by startup funding from the Department of Psychology at the University of Kansas provided to A.A., and the R01MH125740 award from NIH partially supported J.M.G.’s work.
Publisher
Cold Spring Harbor Laboratory
Reference30 articles.
1. The growing role of precision and personalized medicine for cancer treatment
2. N P, MB D, T P. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. In: Adam MP , Feldman J , Mirzaa GM , et al. , eds. GeneReviews®. Seattle (WA): University of Washington, Seattle, 1993. http://www.ncbi.nlm.nih.gov/books/NBK1116/ (accessed July 13, 2024).
3. Personalized Care and Treatment Compliance in Chronic Conditions;JPM,2022
4. Race, APOE genotypes, and cognitive decline among middle-aged urban adults;Alz Res Therapy,2021
5. Race, APOE ?4, and Long-Term Cognitive Trajectories in a Biracial Population Sample;JAD,2019